1684
M. Ziyaadini et al.
2
3JCP = 8.2 Hz, C=O acid), 180.26 (C=S) ppm; 31P NMR
(CDCl3, 202.4 MHz): d = 20.20 (Ph3P?–C) ppm; IR
(KBr): m = 1,647 and 1,400 (COO asym and sym), 1,470
(C=S) cm-1; MS: m/z (%) = 483 (M?, 1), 277 (Ph3PCH3,
9), 262 (Ph3P, 100), 183 (PPh2, 80), 151 (C7H5NOS, 17),
108 (PPh, 26), 77 (Ph, 10), 44 (CO2, 5).
3JHH = 9.1 Hz, JHP = 9.2 Hz, CH2–P), 4.87 (1H, ddd,
2JHH = 16.3 Hz, JHP = 13.1 Hz, JHH = 4.0 Hz, CH2–
2
3
3
3
P), 5.30 (1H, ddd, JHP = 13.4 Hz, JHH = 8.6 Hz,
3JHH = 4.1 Hz, CH–CP), 7.34–7.81 (19H, m, CHarom),
7.95 (1H, s, CH=N) ppm; 13C NMR (CDCl3, 100.6 MHz):
1
d = 27.21 (d, JCP = 53.3 Hz, CH–P), 54.98 (d,
2JCP = 5.0 Hz, CH2–CP), 110.46, 119.91, 122.08,
122.90, 128.44, 133.78, 143.21 (s, 7C of C7H5N2),
2-(2,3-Dihydro-2,3-dioxo-1H-indol-1-yl)-3-(triphenylphos-
phonio)propanoate (4e, C29H22NO4P)
1
118.50 (d, JCP = 87.6 Hz, Cipso), 130.18 (d, JCP
2
13.1 Hz, Cmeta), 133.19 (d, JCP = 10.6 Hz, Cortho),
3
=
1
Orange powder; yield 94%; m.p.: 148–151 °C; H NMR
(CDCl3, 400.2 MHz): d = 3.69 (1H, ddd, 2JHH = 16.1 Hz,
4
3
134.70 (d, JCP = 3.1 Hz, Cpara), 168.83 (d, JCP = 10.1
Hz, C=O acid) ppm; 31P NMR (CDCl3, 162.0 MHz):
d = 20.87 (Ph3P?–C) ppm; IR (KBr): m = 1,639 and 1,400
(COO asym and sym) cm-1; MS: m/z (%) = 450 (M?, 1),
277 (Ph3PCH3, 6), 262 (Ph3P, 100), 183 (PPh2, 80), 132
(C8H9N2, 5), 108 (PPh, 26), 77 (Ph, 9), 44 (CO2, 2).
3
2JHP = 10.3 Hz, JHH = 10.4 Hz, CH2–P), 4.82 (1H, ddd,
2
3
2JHH = 16.7 Hz, JHP = 12.9 Hz, JHH = 2.4 Hz, CH2–
3
P), 5.32 (1H, ddd, JHP = 13.4 Hz, JHH = 11.0 Hz,
3
3JHH = 2.4 Hz, CH–CP), 7.05–7.84 (19H, m, CHarom
)
ppm; 13C NMR (CDCl3, 100.6 MHz): d = 23.90 (d,
1JCP = 53.3 Hz, CH–P), 49.52 (d, JCP = 6.0 Hz, CH2–
CP), 112.67, 117.87, 123.77, 124.95, 138.54, 149.23,
2
2-(2,4-Dioxothiazolidin-3-yl)-3-(triphenylphosphonio)-
propanoate (4h, C24H20NO4PS)
Light yellow powder; yield 90%; m.p.: 94–97 °C; 1H NMR
1
157.96, 182.33 (s, 8C of C8H4NO2), 118.11 (d, JCP
=
3
86.5 Hz, Cipso), 130.40 (d, JCP = 13.1 Hz, Cmeta), 133.55
2
(d, JCP = 10.0 Hz, Cortho), 135.21 (d, JCP = 2.0 Hz,
4
2
(CDCl3, 500.1 MHz): d = 3.58, 3.74 (2H, d, JHH = 17.1
Hz, CH2 heterocyclic), 3.88 (1H, ddd, JHH = 16.0 Hz,
3
2
C
para), 166.67 (d, JCP = 11.1 Hz, C=O acid) ppm; 31P
2
NMR (CDCl3, 162.0 MHz): d = 20.82 (Ph3P?–C) ppm; IR
(KBr): m = 1,735 and 1,650 (C=O heterocyclic), 1,610 and
1,438 (COO asym and sym) cm-1; MS: m/z (%) = 479
(M?, 1), 333 (M - C8H4NO2, 1), 277 (Ph3PCH3, 10), 262
(Ph3P, 100), 183 (PPh2, 64), 108 (PPh, 21), 77 (Ph, 17), 44
(CO2, 13).
3JHH = 9.5 Hz, JHP = 9.4 Hz, CH2–P), 4.76 (1H, ddd,
2JHH = 16.1 Hz, JHP = 14.1 Hz, JHH = 4.0 Hz, CH2–
2
3
3
P), 5.02 (1H, ddd, JHP = 14.0 Hz, JHH = 9.1 Hz,
3
3JHH = 4.0 Hz, CH–CP), 7.28–7.82 (15H, m, CHarom
)
ppm; 13C NMR (CDCl3, 125.7 MHz): d = 22.93 (d,
1JCP = 55.6 Hz, CH–P), 33.44 (s, CH2 heterocyclic),
2
51.28 (d, JCP = 5.1 Hz, CH2–CP), 119.10 (d, JCP
1
=
2-(1,1-Dioxido-3-oxobenzo[d]isothiazol-2(3H)-yl)-3-(tri-
phenylphosphonio)propanoate (4f, C28H22NO5PS)
3
87.2 Hz, Cipso), 130.33 (d, JCP = 12.7 Hz, Cmeta), 133.27
2
(d, JCP = 9.8 Hz, Cortho), 134.89 (d, JCP = 2.3 Hz,
4
White powder; yield 93%; m.p.: 94–98 °C; 1H NMR
3
C
para), 166.61 (d, JCP = 10.5 Hz, C=O acid), 171.38,
(CDCl3, 500.1 MHz): d = 3.88 (1H, ddd, 2JHH = 17.3 Hz,
172.00 (s, 2C=O heterocyclic) ppm; 31P NMR (CDCl3,
202.4 MHz): d = 19.09 (Ph3P?–C) ppm; IR (KBr):
m = 1,749 and 1,678 (C=O heterocyclic), 1,610 and 1,438
(COO asym and sym) cm-1; MS: m/z (%) = 449 (M?, 1),
277 (Ph3PCH3, 12), 262 (Ph3P, 100), 183 (PPh2, 84), 115
(C3H3NO2S, 9), 108 (PPh, 71), 77 (Ph, 12), 44 (CO2, 20).
2
3JHH = 9.5 Hz, JHP = 9.4 Hz, CH2–P), 4.69 (1H, ddd,
2
3
2JHH = 16.8 Hz, JHP = 13.2 Hz, JHH = 6.9 Hz, CH2–
3
P), 4.85 (1H, ddd, JHP = 13.5 Hz, JHH = 8.9 Hz,
3
3JHH = 6.7 Hz, CH–CP), 7.53–7.95 (19H, m, CHarom
)
ppm; 13C NMR (CDCl3, 125.7 MHz): d = 24.79 (d,
1JCP = 49.1 Hz, CH–P), 49.99 (d, JCP = 4.1 Hz, CH2–
CP), 116.33, 117.06, 119.73, 123.42, 131.52, 131.82,
2
Acknowledgments We gratefully acknowledge the financial sup-
port from the Research Council of University of Sistan and
Baluchestan.
1
168.85 (s, 7C of C7H4NO3S), 118.60 (d, JCP = 83.4 Hz,
C
ipso), 130.65 (d, 3JCP = 13.2 Hz, Cmeta), 133.85 (d, 2JCP
=
4
10.6 Hz, Cortho), 135.68 (d, JCP = 2.7 Hz, Cpara), 166.71
(d, JCP = 10.1 Hz, C=O acid) ppm; 31P NMR (CDCl3,
3
202.4 MHz): d = 18.95 (Ph3P?–C) ppm; IR (KBr):
m = 1,728 (C=O heterocyclic), 1,638 and 1,438 (COO
asym and sym), 1,338 (SO2) cm-1; MS: m/z (%) = 515
(M?, 1), 277 (Ph3PCH3, 7), 262 (Ph3P, 100), 183 (PPh2, 74),
108 (PPh, 30), 77 (Ph, 6), 44 (CO2, 18).
References
1. Nakamura M, Miki M, Majima TJ (2000) J Chem Soc Perkin
Trans 2:1447
2. Yasui S, Tojo S, Majima T (2005) J Org Chem 70:1276
3. Corbridge DEC (1995) Phosphorus: an outline of its chemistry,
biochemistry and uses, 5th edn. Elsevier, Amsterdam
4. Engel R (1988) Synthesis of carbon–phosphorus bond. CRC,
Boca Raton
5. Cadogan JIG (1979) Organophosphorus reagents in organic
synthesis. Academic, New York
6. Johnson AW (1966) Ylide chemistry. Academic, London
2-(1H-Benzo[d]imidazol-1-yl)-3-(triphenylphospho-
nio)propanoate (4g, C28H23N2O2P)
Cream powder; yield 91%; m.p.: 90–92 °C; 1H NMR
(CDCl3, 400.2 MHz): d = 4.03 (1H, ddd, 2JHH = 15.8 Hz,
123